Centre Testing International Group Co. Ltd. Stock
Stocks
300012
CNE100000GV8
Business Support Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.81 CNY | +3.76% |
|
-1.07% | +1.92% |
| 04-28 | Bioduro and Cti Biotechnology Form Strategic Partnership for Preclinical Drug Development | CI |
| 04-21 | Declaration of Voting Results by Centre Testing International | CI |
| Market Cap | 23.1B 3.41B 2.98B 2.75B 2.53B 4.79B 328B 4.88B 32.85B 12.89B 160B 12.81B 12.53B 553B | P/E 2026 * |
19.6x | P/E 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise Value | 21.3B 3.15B 2.75B 2.54B 2.33B 4.42B 303B 4.5B 30.29B 11.89B 148B 11.81B 11.56B 510B | EV / Sales 2026 * |
2.81x | EV / Sales 2027 * | 2.46x |
| Free-Float |
79.89% | Yield 2026 * |
1.33% | Yield 2027 * | 1.56% |
| 1 day | +3.76% | ||
| 1 week | -1.07% | ||
| Current month | -0.36% | ||
| 1 month | -0.72% | ||
| 3 months | -10.90% | ||
| 6 months | -4.76% | ||
| Current year | +1.92% |
| 1 week | 12.85 |  | 14.13 |
| 1 month | 12.85 | | 15.3 |
| Current year | 12.85 | | 17.97 |
| 1 year | 11.97 | | 17.97 |
| 3 years | 9.48 | | 21.1 |
| 5 years | 9.48 | | 30.6 |
| 10 years | 3.36 | | 35.3 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/12/22 | Sell | 230,000 | 0.0151% | |||
| 29/12/22 | Sell | Chairperson | 750,000 | 0.0492% | ||
| 29/12/22 | Sell | 100,000 | 0.0066% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.76% | -1.07% | +13.57% | -29.79% | 3.29B | |
| +0.25% | +1.09% | +14.24% | +15.66% | 23.12B | |
| +1.51% | -2.15% | +19.34% | - | 17.65B | |
| -5.84% | -17.13% | +56.66% | +25.62% | 3.29B | |
| -0.47% | -4.02% | +169.37% | +202.37% | 2.23B | |
| +1.12% | +4.12% | -34.71% | -43.50% | 1.85B | |
| +2.89% | -8.07% | -37.05% | - | 1.58B | |
| +0.09% | -19.89% | +144.10% | +207.29% | 1.56B | |
| +1.47% | -6.08% | -2.70% | +4.91% | 1.55B | |
| +1.46% | -3.93% | -10.00% | -6.44% | 1.31B | |
| Average | +0.61% | -6.48% | +33.28% | +47.01% | 5.74B | |
| Weighted average by Cap. | +0.57% | -5.70% | +23.75% | +27.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.57B 1.12B 978M 902M 829M 1.57B 108B 1.6B 10.77B 4.22B 52.59B 4.2B 4.11B 181B | 8.52B 1.26B 1.1B 1.02B 933M 1.77B 121B 1.8B 12.12B 4.75B 59.19B 4.73B 4.62B 204B |
| Net income | 1.19B 176M 153M 142M 130M 247M 16.89B 251M 1.69B 663M 8.26B 659M 645M 28.45B | 1.37B 203M 177M 163M 150M 285M 19.51B 290M 1.95B 766M 9.53B 761M 745M 32.86B |
| Net Debt | -1.8B -266M -233M -215M -197M -374M -25.59B -380M -2.56B -1B -12.51B -999M -977M -43.12B | -2.12B -313M -274M -252M -232M -440M -30.12B -447M -3.01B -1.18B -14.72B -1.18B -1.15B -50.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | CN¥13.81 | +3.76% | 38,656,560 |
| 14/07/26 | CN¥13.31 | +1.76% | 24,973,061 |
| 13/07/26 | CN¥13.08 | -3.33% | 45,363,873 |
| 10/07/26 | CN¥13.53 | +0.37% | 43,749,913 |
| 09/07/26 | CN¥13.48 | -0.22% | 35,963,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 300012 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
